{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T05:57:32Z","timestamp":1788587852382,"version":"build-2803163510"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.jsat.2019.10.002","type":"journal-article","created":{"date-parts":[[2019,10,24]],"date-time":"2019-10-24T13:04:06Z","timestamp":1571922246000},"page":"24-28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Differential adoption of opioid agonist treatments in detoxification and outpatient settings"],"prefix":"10.1016","volume":"107","author":[{"given":"Kelly E.","family":"Dunn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew S.","family":"Huhn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric C.","family":"Strain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jsat.2019.10.002_bb0005","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1176\/appi.ps.201700196","article-title":"State-targeted funding and technical assistance to increase access to medication treatment for opioid use disorder","volume":"69","author":"Abraham","year":"2017","journal-title":"Psychiatric Services"},{"key":"10.1016\/j.jsat.2019.10.002_bb0010","article-title":"Methadone at tapered doses for the management of opioid withdrawal","volume":"2","author":"Amato","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1016\/j.jsat.2019.10.002_bb0015","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1081\/ADA-100103117","article-title":"One-, three-, and six-month outcomes after brief inpatient opioid detoxification","volume":"27","author":"Chutuape","year":"2001","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"issue":"2","key":"10.1016\/j.jsat.2019.10.002_bb0020","doi-asserted-by":"crossref","first-page":"182","DOI":"10.2105\/AJPH.2017.304187","article-title":"Opioid crisis: No easy fix to its social and economic determinants","volume":"108","author":"Dasgupta","year":"2018","journal-title":"American Journal of Public Health"},{"issue":"1","key":"10.1016\/j.jsat.2019.10.002_bb0025","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1360-0443.2010.03140.x","article-title":"Mortality among regular or dependent users of heroin and other opioids: A systematic review and meta-analysis of cohort studies","volume":"106","author":"Degenhardt","year":"2011","journal-title":"Addiction (Abingdon, England)"},{"issue":"11","key":"10.1016\/j.jsat.2019.10.002_bb0030","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1001\/jama.2017.9308","article-title":"Contribution of opioid-involved poisoning to the change in life expectancy in the United States, 2000\u20132015","volume":"318","author":"Dowell","year":"2017","journal-title":"Jama"},{"issue":"12","key":"10.1016\/j.jsat.2019.10.002_bb0035","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1001\/jamainternmed.2014.5302","article-title":"Primary care-based buprenorphine taper vs maintenance therapy for prescription opioid dependence: A randomized clinical trial","volume":"174","author":"Fiellin","year":"2014","journal-title":"JAMA Internal Medicine"},{"key":"10.1016\/j.jsat.2019.10.002_bb0040","doi-asserted-by":"crossref","DOI":"10.1177\/1178632918813321","article-title":"Opioid-related harms: Simplistic solutions to the crisis ineffective and cause collateral damage","volume":"11","author":"Gallagher","year":"2018","journal-title":"Health Services Insights"},{"issue":"16","key":"10.1016\/j.jsat.2019.10.002_bb0045","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1001\/jama.2017.13358","article-title":"Reframing the opioid epidemic as a national emergency","volume":"318","author":"Gostin","year":"2017","journal-title":"Jama"},{"key":"10.1016\/j.jsat.2019.10.002_bb0050","article-title":"Buprenorphine for managing opioid withdrawal","volume":"2","author":"Gowing","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.jsat.2019.10.002_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsat.2017.04.005","article-title":"Why aren\u2019t physicians prescribing more buprenorphine?","volume":"78","author":"Huhn","year":"2017","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2019.10.002_bb0060","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.drugalcdep.2017.08.019","article-title":"The relationship between treatment accessibility and preference amongst out-of-treatment individuals who engage in non-medical prescription opioid use","volume":"180","author":"Huhn","year":"2017","journal-title":"Drug and Alcohol Dependence"},{"issue":"9","key":"10.1016\/j.jsat.2019.10.002_bb0065","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/nn0901-943","article-title":"The role of withdrawal in heroin addiction: Enhances reward or promotes avoidance?","volume":"4","author":"Hutcheson","year":"2001","journal-title":"Nature Neuroscience"},{"issue":"8","key":"10.1016\/j.jsat.2019.10.002_bb0070","first-page":"105","article-title":"National and state treatment need and capacity for opioid agonist medication-assisted treatment","author":"Jones","year":"2015","journal-title":"Journal Information"},{"key":"10.1016\/j.jsat.2019.10.002_bb0075","series-title":"A major expansion of opioid agonist treatment is needed to reduce overdose deaths in the USA","author":"Larney","year":"2019"},{"issue":"10118","key":"10.1016\/j.jsat.2019.10.002_bb0080","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0140-6736(17)32812-X","article-title":"Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X: BOT): A multicentre, open-label, randomised controlled trial","volume":"391","author":"Lee","year":"2018","journal-title":"The Lancet"},{"issue":"3","key":"10.1016\/j.jsat.2019.10.002_bb0085","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1214\/11-AOAS471","article-title":"A bayesian joinpoint regression model with an unknown number of break-points","volume":"5","author":"Martinez-Beneito","year":"2011","journal-title":"The Annals of Applied Statistics"},{"key":"10.1016\/j.jsat.2019.10.002_bb0090","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.pbb.2017.04.006","article-title":"Modulation of drug choice by extended drug access and withdrawal in rhesus monkeys: Implications for negative reinforcement as a driver of addiction and target for medications development","volume":"164","author":"Negus","year":"2018","journal-title":"Pharmacology Biochemistry and Behavior"},{"key":"10.1016\/j.jsat.2019.10.002_bb0095","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jsat.2018.06.008","article-title":"US hospital discharges documenting patient opioid use disorder without opioid overdose or treatment services, 2011\u20132015","volume":"92","author":"Peterson","year":"2018","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1\u20132","key":"10.1016\/j.jsat.2019.10.002_bb0100","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.drugalcdep.2009.11.008","article-title":"Mortality among drug users after discharge from inpatient treatment: An 8-year prospective study","volume":"108","author":"Ravndal","year":"2010","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.jsat.2019.10.002_bb0105","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1370\/afm.1735","article-title":"Geographic and specialty distribution of US physicians trained to treat opioid use disorder","volume":"13","author":"Rosenblatt","year":"2015","journal-title":"Annals of Family Medicine"},{"issue":"5","key":"10.1016\/j.jsat.2019.10.002_bb0110","doi-asserted-by":"crossref","first-page":"917","DOI":"10.2105\/AJPH.2012.301049","article-title":"Opioid agonist treatments and heroin overdose deaths in Baltimore, Maryland, 1995\u20132009","volume":"103","author":"Schwartz","year":"2013","journal-title":"American Journal of Public Health"},{"issue":"11","key":"10.1016\/j.jsat.2019.10.002_bb0115","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1001\/jama.2016.10542","article-title":"Physician capacity to treat opioid use disorder with buprenorphine-assisted treatment","volume":"316","author":"Stein","year":"2016","journal-title":"Jama"},{"issue":"12","key":"10.1016\/j.jsat.2019.10.002_bb0120","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1001\/jamapsychiatry.2017.3206","article-title":"Effectiveness of injectable extended-release naltrexone vs daily buprenorphine-naloxone for opioid dependence: A randomized clinical noninferiority trial","volume":"74","author":"Tanum","year":"2017","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"10.1016\/j.jsat.2019.10.002_bb0125","doi-asserted-by":"crossref","first-page":"73","DOI":"10.7326\/M17-2854","article-title":"More beds or more chairs? Using a science-based approach to address the opioid epidemic","volume":"168","author":"Tetrault","year":"2018","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.jsat.2019.10.002_bb0130","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.drugalcdep.2017.10.002","article-title":"Prescribing patterns of buprenorphine waivered physicians","volume":"181","author":"Thomas","year":"2017","journal-title":"Drug and Alcohol Dependence"},{"issue":"2","key":"10.1016\/j.jsat.2019.10.002_bb0135","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1080\/10826084.2017.1363238","article-title":"Barriers to medications for addiction treatment: How stigma kills","volume":"53","author":"Wakeman","year":"2018","journal-title":"Substance Use & Misuse"},{"issue":"2","key":"10.1016\/j.jsat.2019.10.002_bb0140","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1177\/0033354916688206","article-title":"How states are tackling the opioid crisis","volume":"132","author":"Wickramatilake","year":"2017","journal-title":"Public Health Reports"},{"issue":"5","key":"10.1016\/j.jsat.2019.10.002_bb0145","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1016\/j.csda.2006.07.044","article-title":"Estimating joinpoints in continuous time scale for multiple change-point models","volume":"51","author":"Yu","year":"2007","journal-title":"Computational Statistics & Data Analysis"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547219301898?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547219301898?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:50:07Z","timestamp":1760039407000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547219301898"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":29,"alternative-id":["S0740547219301898"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2019.10.002","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential adoption of opioid agonist treatments in detoxification and outpatient settings","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2019.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}